phenylpropanolamine drug combination chlorpheniramine

originally contained 12.5 mg phenylpropanolamine and 2 mg chlorpheniramine; new formulation as of 1993 contains 6.25 mg phenylpropanolamine and 1 mg chlorpheniramine; koldakt , an Indian drug, is a delayed-action preparation in capsule form

Also Known As:

chlorpheniramine, phenylpropanolamine drug combination; Coldact; Koldakt; Triaminic syrup; chlorpheniramine - phenylpropanolamine

Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

Respiratory Tract Diseases (Respiratory Tract Disease)

01/01/1993 - "[Trial of a long-acting preparation Coldact from the firm NATKO to treat upper respiratory tract diseases in polyclinics]."
01/01/1994 - "[Use of coldact, a long-acting preparation of NATKO for the treatment of upper respiratory tract diseases in outpatient clinics]."
01/01/1993 - "[A trial of the use of the prolonged-action preparation Koldakt from the Natko firm for treating upper respiratory tract diseases in polyclinics]."

Related Drugs and Biologics

1.	Delayed-Action Preparations